| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.387 | 4.324 | 4.646 | 5.886 | 3.881 | 2.825 | - | - | - | 11.328 |
| Total Income - EUR | 2.387 | 4.324 | 4.650 | 5.886 | 3.881 | 5.269 | - | - | - | 11.328 |
| Total Expenses - EUR | 3.577 | 2.562 | 5.734 | 2.869 | 4.570 | 6.815 | - | - | - | 12.405 |
| Gross Profit/Loss - EUR | -1.190 | 1.762 | -1.084 | 3.017 | -689 | -1.546 | - | - | - | -1.077 |
| Net Profit/Loss - EUR | -1.261 | 1.632 | -1.223 | 2.840 | -806 | -1.628 | - | - | - | -1.077 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 |
Check the financial reports for the company - Gamma - Med Nuclear Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 31 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 |
| Current Assets | 708 | 2.023 | 1.256 | 2.113 | 1.266 | 4.343 | - | - | - | 1.097 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 70 | - | - | - | 0 |
| Cash | 708 | 2.023 | 1.256 | 2.113 | 1.266 | 4.273 | - | - | - | 1.097 |
| Shareholders Funds | -1.216 | 428 | -802 | 2.053 | 1.207 | -443 | - | - | - | 1.097 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | 40 |
| Debts | 1.956 | 1.595 | 2.058 | 60 | 58 | 4.786 | - | - | - | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gamma - Med Nuclear Srl